Furthermore, intratumoral treatment of melanoma-bearing mice with low dose stimulator of interferon genes (STING) agonist (ADU S-100) normalizes angiogenic blood vessels and upregulates TLS-inducing factors such as Ccl19, Ccl21, LTαβ and LIGHT (110). The gene discussed is STING1; the disease is melanoma.